Results 21 to 30 of about 514,439 (307)
Time-to- failure under different causes of failure is known as a competing risks model. Practice, competing risks data can be appeared in different applications such as engineering fields or biological and medical lifetime studies as well as other ...
Tahani.A. Abushal +2 more
doaj +1 more source
Competing Risks In Mortality Analysis [PDF]
In this paper we present a brief review of the concept of competing risks and the statistical methods of mortality analysis including estimation of three types of probability of dying with respect to a particular cause of death. We will describe formulas of estimates for cohort studies medical follow-up studies and analyses of mortality data for a ...
openaire +2 more sources
Competing risk models to estimate the excess mortality and the first recurrent-event hazards [PDF]
Background In medical research, one common competing risks situation is the study of different types of events, such as disease recurrence and death. We focused on that situation but considered death under two aspects: "expected death" and "excess death",
Belot Aurélien +14 more
core +1 more source
Understanding competing risks: a simulation point of view
Background Competing risks methodology allows for an event-specific analysis of the single components of composite time-to-event endpoints. A key feature of competing risks is that there are as many hazards as there are competing risks.
Wanner Christoph +4 more
doaj +1 more source
Competing-risks model for pre-eclampsia and adverse pregnancy outcomes.
The competing risks model for assessment of risk for pre-eclampsia (PE) at 35-36 weeks' gestation identifies the majority of women whose pregnancies are at high-risk for subsequent delivery with PE. To objective of this study was to examine, according to
Wright, A +6 more
core +1 more source
Competing-risks model for prediction of small-for-gestational-age neonates at 36 weeks' gestation.
To develop further a new competing risks model for the prediction of small-for-gestational-age (SGA) neonates, by including sonographically estimated fetal weight (EFW) and biomarkers of impaired placentation at 36 weeks' gestation.
Dimopoulou, S +5 more
core +1 more source
Background To illustrate the 10-year risks of urinary adverse events (UAEs) among men diagnosed with prostate cancer and treated with different types of therapy, accounting for the competing risk of death.
Charlotte A. Bolch +5 more
doaj +1 more source
Competing risks models and time-dependent covariates [PDF]
New statistical models for analysing survival data in an intensive care unit context have recently been developed. Two models that offer significant advantages over standard survival analyses are competing risks models and multistate models.
Adrian Barnett +3 more
core +1 more source
Phosphatidylinositol 4‐kinase as a target of pathogens—friend or foe?
This graphical summary illustrates the roles of phosphatidylinositol 4‐kinases (PI4Ks). PI4Ks regulate key cellular processes and can be hijacked by pathogens, such as viruses, bacteria and parasites, to support their intracellular replication. Their dual role as essential host enzymes and pathogen cofactors makes them promising drug targets.
Ana C. Mendes +3 more
wiley +1 more source
Competing risks to breast cancer mortality in Catalonia
Background Breast cancer mortality has experienced important changes over the last century. Breast cancer occurs in the presence of other competing risks which can influence breast cancer incidence and mortality trends. The aim of the present work is: 1)
Espinàs Josep-Alfons +6 more
doaj +1 more source

